4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001423898-25-000005
Director sold 46,463 shares at an average $355.32 ($16,509,032)
- Director acquired 46,463 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2025-08-11 | Option exercise 10b5-1 | +3,200 | $9.45 | $30,240 | 464,244 | D: show line 1 in the form |
| Taub Rebecca Director | 2025-08-11 | Sale 10b5-1 | −2,980 | $350.18 | $1,043,528 | 461,264 | D: show line 2 in the form |
| Taub Rebecca Director | 2025-08-11 | Sale 10b5-1 | −220 | $351.02 | $77,225 | 461,044 | D: show line 3 in the form |
| Taub Rebecca Director | 2025-08-12 | Option exercise 10b5-1 | +43,263 | $9.45 | $408,835 | 504,307 | D: show line 4 in the form |
| Taub Rebecca Director | 2025-08-12 | Sale 10b5-1 | −3,580 | $350.87 | $1,256,127 | 500,727 | D: show line 5 in the form |
| Taub Rebecca Director | 2025-08-12 | Sale 10b5-1 | −2,870 | $351.60 | $1,009,091 | 497,857 | D: show line 6 in the form |
| Taub Rebecca Director | 2025-08-12 | Sale 10b5-1 | −1,175 | $352.45 | $414,130 | 496,682 | D: show line 7 in the form |
| Taub Rebecca Director | 2025-08-12 | Sale 10b5-1 | −4,587 | $354.04 | $1,623,997 | 492,095 | D: show line 8 in the form |
| Open-market sales · 46,463 sh · avg $355.32 · $16,509,032 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2025-08-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,200 | 43,263 | D: show line 15 in the form | ||
| Taub Rebecca Director | 2025-08-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,263 | 0 | D: show line 16 in the form |
Loading xslF345X05/wk-form4_1755120803.xml…